Cytokine activation of endothelial cells: New molecules for an old paradigm

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 406-414

  Mantovani, Alberto ^a,b   Sozzani, Silvano ^a   Vecchi, Annunciata ^a   Introna, Martino ^a   Allavena, Paola ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0030857057     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657561     Document Type: Conference Paper

References (116)

1. Mantovani A., Bussolino F., and Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bed side. Immunol Today 1997; in press:
2. Mantovani A. and Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-375.
3. Mantovani A., Bussolino F., and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591-2599.
4. Bussolino F. and Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 1995; 229: 327-337.
5. Montrucchio G., Lupia E., Battaglia E., Passerini G., Bussolino F., Emanuelli G., and Camussi G. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994; 180: 377-382.
6. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A.J., Shin W.S., and Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
7. Peng H.B., Rajavashisth T.B., Libby P., and Liao J.K. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050-17055.
8. Zeiher A.M., Fisslthaler B., Schray Utz B., and Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980-986.
9. Peng H.B., Libby P., and Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270: 14214-14219.
10. Kilgore K.S., Shen J.P., Miller B.F., Ward P.A., and Warren J.S. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 1434-1441.
11. Saadi S., Holzknecht R.A., Patte C., Stern D.M., and Platt J.L. Complement-mediated regulation of tissue factor activity in endothelium . J Exp Med 1995; 182: 1807-1814.
12. Breviario F., d'Aniello E.M., Golay J., Peri G., Bottazzi B., Bairoch A., Saccone S., Marzella R., Predazzi V., Rocchi M., Della Valle G., Dejana E., Mantovani A., and Introna M. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190-22197.
13. Introna M., Vidai Alles V., Castellano M., Picardi G., De Gioia L., Bottazzi B., Peri G., Breviario F., Salmona M., De Gregorio L., Dragani T.A., Srinivasan N., Blundell T.L., Hamilton T.A., and Mantovani A. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996; 87: 1862-1872.
14. Pober J. and Cotran R.S. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-451.
15. Maier J.A., Statuto M., and Ragnotti G. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994; 14: 1845-1851.
16. Bradley J.R., Thiru S., and Pober J.S. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995; 146: 27-32.
17. Mackay F., Loetscher H., Stueber D., Gehr G., and Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993; 177: 1277-1286.
18. Paleolog E.M., Delasalle S.A., Buurman W.A., and Feldmann M. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 1994; 84: 2578-2590.
19. Grell M., Douni E., Wajant H., Löheden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
20. Schmid E.F., Binder K., Grell M., Scheurich P., and Pfizenmaier K. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood 1995; 86: 1836-1841.
21. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., and Kunkel S.L. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood 1995; 86: 2767-2773.
22. Colotta F., Dower S.K., Sims J.E., and Mantovani A. The type II 'decoy' receptor: novel regulatory pathway for interleukin-1. Immunol Today 1994; 15: 562-566.
23. Grosset C., Jazwiec B., Taupin J.L., Liu H., Richard S., Mahon F.X., Reiffers J., Moreau J.F., and Ripoche J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 1995; 86: 3763-3770.
24. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Manapatra B.D., Rouvier E., Goldstein P., Banchereau J., and Lebecque S. T-cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593-2603.
25. Yan S.F., Tritto I., Pinsky D., Liao H., Huang J., Fuller G., Brett J., May L., and Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471.
26. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., and Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549-553.
27. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., Van Hinsberg V., Sozzani S., Bussolino F., Poli V., Ciliberto G., and Mantovani A. IL-6, in concert with soluble IL-6 receptor, selectively induces chemokine production in endothelial cells and participates in the leukocyte recruitment in vivo. Immunity 1997; in press:
28. Bussolino F., Bocchietto E., Silvagno F., Soldi R., Arese M., and Mantovani A. Actions of molecules which regulate hemopeiesis on endothelial cells: memoirs of common ancestors? Path Res Pract 1994; 190: 834-839.
29. Korpelainen E.I., Gamble J.R., Smith W.B., Dottore M., Vadas M.A., and Lopez A.F. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 1995; 86: 176-182.
30. Sironi M., Munoz C., Pollicino T., Siboni A., Sciacca F.L., Bernasconi S., Vecchi A., Colotta F., and Mantovani A. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 1993; 23: 2692-2695.
31. Chen C.C. and Manning A.M. TGF-beta1, IL-10 and EL-4 differentially modulate the cytokine-induced expression of the IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8: 58-65.
32. Debeaux A.C., Maingay J.P., Ross J.A., Fearon K.C.H., and Carter D.C. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J Interferon Cytokine Res 1995; 15: 441-445.
33. Vora M., Yssel H., de Vries J.E., and Karasek M.A. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of EFN-gamma and IL-10. J Immunol 1994; 152: 5734-5741.
34. Schoedon G., Schneemann M., Blau N., Edgell C.J., and Schaffner A. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem Biophys Res Commun 1993; 196: 1343-1348.
35. Eissner G., Kohlhuber F., Grell M., Ueffing M., Scheurich P., Hieke A., Multhoff G., Bornkamm G.M., and Holler E. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endoxin. Blood 1995; 86: 4184-4193.
36. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995; 45: 61-65.
37. Wojta J., Gallicchio M., Zoellner H., Filonzi E.L., Hamilton J.A., and Mcgrath K. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 1993; 81: 3285-3292.
38. Marfaingkoka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., and Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells - Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995; 154: 1870-1878.
39. Sironi M., Sciacca F.L., Matteucci C., Conni M., Vecchi A., Bernasconi S., Minty A., Caput D., Ferrara P., Colotta F., and Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84: 1913-1921.
40. Garcia de Frutos P., Hardig Y., and Dahlback B. Serum amyloid P component binding to C4b-binding protein. J Biol Chem 1995; 270: 26950-26955.
41. Hollenbaugh D., Mischel Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., and Aruffo A. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40.
42. Yellin M.J., Brett J., Baum D., Matsushima A., Szabolcs A., Stern D., and Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995; 182: 1857-1864.
43. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., and Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995; 92: 4342-4346.
44. Voest E.E., Kenyon B.M., O'Reilly M.S., Truitt G., D'Amato R.J., and Folkman J. Inhibition of angiogenesis in vivo by interleukin-12. J Natl Cancer Inst 1995; 87: 581-586.
45. Kaplanski G., Farnarier C., Kaplanski S., Porat R., Shapiro L., Bongrand P., and Dinarello C.A. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84: 4242-4248.
46. Brown Z., Gerritsen M.E., Carley W.W., Strieter R.M., Kunkel S.L., and Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells - Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol 1994; 145: 913-921.
47. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Einer V.M., Einer S.G., and Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801.
48. Schonbeck U., Brandt E., Petersen F., Flad H.D., and Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995; 154: 2375-2383.
49. Petzelbauer P., Watson C.A., Pfau S.E., and Pober J.S. IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995; 7: 267-272.
50. Luster A.D., Greenberg S.M., and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219-231.
51. Angiolillo A.L., Sgadari C., Taub D.D., Liao F., Farber J.M., Maheshwari S., Kleinman H.K., Reaman G.H., and Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995; 182: 155-162.
52. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D., Chan S.Y., Roczniak S., and Shanafelt A.B. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis . J Biol Chem 1995; 270: 27348-27357.
53. Cao Y.H., Chen C., Weatherbee J.A., Tsang M., and Folkman J. gro-beta, a -C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 1995; 182: 2069-2077.
54. Peiper S.C., Wang Z.X., Neote K., Martin A.W., Showell H.J., Conklyn M.J., Ogborne K., Hadley T.J., Lu Z.H., Hesselgesser J., and Horuk R. The Duffy antigen receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317.
55. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294.
56. Ley K., Baker J.B., Cybulsky M.I., Gimbrone M.A., and Luscinskas F.W. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993; 151: 6347-6357.
57. Colotta F., Orlando S., Fadlon E.J., Sozzani S., Matteucci C., and Mantovani A. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995; 181: 2181-2188.
58. van Hinsbergh V.W., Vermeer M., Koolwijk P., Grimbergen J., and Kooistra T. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 1994; 84: 2984-2991.
59. Palmer-Crocker R.L. and Pober J.S. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J Immunol 1995; 154: 2838-2845.
60. Schieven G.L., Kallestad J.C., Brown T.J., Ledbetter J.A., and Linsley P.S. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase. J Immunol 1992; 149: 1676-1682.
61. Weber C., Negrescu E., Erl W., Pietsch A., Frankenberger M., Ziegler Heitbrock H.W., Siess W., and Weber P.C. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 1995; 155: 445-451.
62. Modur V., Zimmerman G.A., Prescott S.M., and McIntyre T.M. Endothelial cell inflammatory responses to tumor necrosis factor alpha - Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem 1996; 271: 13094-13102.
63. De Luca L.G., Johnson D.R., Whitley M.Z., Tucker C., and Pober J.S. cAMP and Tumor Necrosis Factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the Endothelial Leukocyte Adhesion Molecule-1 (E-selectin) promoter. J Biol Chem 1994; 269: 19193-19196.
64. Whitley M.Z., Thanos D., Read M.A., Maniatis T., and Collins T. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14: 6464-6475.
65. Kaszubska W., van Huijsduijnen R.H., Ghersa P., DeRaemy Schenk A.M., Chen B.P., Hai T., DeLamarter J.F., and Whelan J. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 1993; 13: 7180-7190.
66. Pober J.S., Slowik M.R., De Luca L.G., and Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-5123.
67. Ghersa P., Hooft van Huijsduijnen R., Whelan J., Cambet Y., Pescini R., and DeLamarter J.F. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994; 269: 29129-29137.
68. Masamune A., Igarashi Y., and Hakomori S. Regulatory role of ceramide in interleukin (IL)-1 beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 1996; 271: 9368-9375.
69. Wiegmann K., Schütze S., Machleidt T., Witte D., and Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in Tumor Necrosis Factor signaling. Cell 1994; 78: 1005-1015.
70. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J., and Krönke M. FAN, a novel WD-repeat protein couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996; 86: 937-947.
71. Palmer-Crocker R.L., Hugles C.C.W., and Pober J.S. IL-4 andIL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gammaC chain. J Clin Invest 1996; 98: 604-609.
72. Verbsky J.W., Bach E.A., Fang Y.F., Yang L., Randolph D.A., and Fields L.E. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem 1996; 271: 13976-13980.
73. Schnyder B., Lugli S., Feng N., Etter H., Lutz R.A., Ryffel B., Sugamura K., Wunderli-Allenspach H., and Moser R. IL-4 and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain (gamma-c). Blood 1996; 87: 4286-4295.
74. Soldi R., Primo L., Brizzi M.F., Sanavio F., Polentarutti N., Aglietta M., Mantovani A., Pegoraro L., and Bussolino F. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony stimulating factor. Blood 1997; in press:
75. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., and Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996; 97: 1715-1722.
76. Miyaloto S., Maki M., Schmitt M.J., Hatanaka M., and Verna I.M. Tumor necrosis factor alpha-induced phosphorylation of IkBalpha is signal for its degradation but not dissociation from NF-kB. Proc Natl Acad Sci USA 1994; 91: 12740-12744.
77. Read M.A., Whitley M.Z., Williams A.J., and Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512.
78. Bennett B.L., Lacson R.G., Chen C.C., Cruz R., Wheeler J.S., Kletzien R.F., Tomasselli A.G., Heinrikson R.L., and Manning A.M. Identification of signal-induced IkB-a kinases in human endothelial cells. . J Biol Chem 1996; 271: 19680-19688.
79. Chen C.C., Rosenbloom C.L., Anderson D.C., and Manning A.M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 1995; 155: 3538-3545.
80. Johnson D.R., Douglas I., Jahnke A., Ghosh S., and Pober J.S. A sustained reduction in IKappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 1996; 271: 16317-16322.
81. Wrighton C.J., Hofer Warbinek R., Moll T., Eytner R., Bach F.H., and de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkappaBalpha, an inhibitor of the transcription factor NF-kappaB. J Exp Med 1996; 183: 1013-1022.
82. Faruqi R., de la Motte C., and DiCorleto P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94: 592-600.
83. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., and Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1874.
84. Orthner C.L., Rodgers G.M., and Fitzgerald L.A. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 1995; 86: 436-443.
85. Read M.A., Neish A.S., Luscinskas F.W., Palombella V.J., Maniatis T., and Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocytes adhesion molecule expression. Immunity 1995; 2: 493-506.
86. de Martin R., Vanhove B., Cheng Q., Hofer E., Csizmadia V., Winkler H., and Bach F.H. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J 1993; 12: 2773-2779.
87. Groves R.W., Giri J., Sims J., Dower S.K., and Kupper T.S. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implication for IL-1-mediated processes in epidermis . J Immunol 1995; 154: 4065-4072.
88. d'Aniello E.M., Breviario F., Martin Padura I., Lampugnani M.G., Dejana E., Mantovani A., and Introna M. Interleukin-1 and tumor necrosis factor induce transient expression of an inhibitor of nuclear factor kB in endothelial cells. Endothelium 1993; 1: 161-165.
89. Lindner V. and Collins T. Expression of NF-kB and IkB-alpha by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148: 427-438.
90. Dixit V.M., Green S., Sarma V., Holzman L.B., Wolf F.W., O'Rourke K., Ward P.A., Prochownik E.V., and Marks R.M. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990; 265: 2973-2978.
91. Opipari A.W.J., Hu H.M., Yabkowitz R., and Dixit V.M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424-12427.
92. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., and Ferran C. A20 bloks endothelial cell activation through a NF-kappaB-dependent machanism. J Biol Chem 1996; 271: 18068-18073.
93. Miyagishi R., Kikuchi S., Fukazawa T., and Tashiro K. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neurol Sci 1995; 129: 223-227.
94. Ahmad M., Marui N., Alexander R.W., and Medford R.M. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 1995; 270: 8976-8983.
95. Schindler U. and Baichwal V.R. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994; 14: 5820-5831.
96. Hooft van Huijsduijnen R., Pescini R., and DeLamarter J.F. Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element. Nucleic Acids Res 1993; 21: 3711-3717.
97. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
98. Pescini R., Kaszubska W., Whelan J., DeLamarter J.F., and Hooft van Huijsduijnen R. ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. J Biol Chem 1994; 269: 1159-1165.
99. Lewis H., Kaszubska W., DeLamarter J.F., and Whelan J. Cooperatively between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol Cell Biol 1994; 14: 5701-5709.
100. Neish A.S., Williams A.J., Palmer H.J., Whitley M.Z., and Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992; 176: 1583-1593.
101. Iademarco M.F., McQuillan J.J., Rosen G.D., and Dean D.C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267: 16323-16329.
102. Shu H.B., Agranoff A.B., Nabel E.G., Leung K., Duckett C.S., Neish A.S., Collins T., and Nabel G.J. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol Cell Biol 1993; 13: 6283-6289.
103. Neish A.S., Khachigian L.M., Park A., Baichwal V.R., and Collins T. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J Biol Chem 1995; 270: 28903-28909.
104. Neish A.S., Read M.A., Thanos D., Pine R., Maniatis T., and Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995; 15: 2558-2569.
105. Gille J., Swerlick R.A., Lawley T.J., and Caughman S.W. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 1996; 87: 211-217.
106. Ledebur H.C. and Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells - Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270: 933-943.
107. Parry G.C. and Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20823-20825.
108. Hou J., Baichwal V., and Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1994; 91: 11641-11645.
109. Look D.C., Pelletier M.R., and Holtzman M.J. Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem 1994; 269: 8952-8958.
110. Roebuck K.A., Rahman A., Lakshminarayanan V., Janakidevi K., and Malik A.B. H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995; 270: 18966-18974.
111. Bierhaus A., Zhang Y., Deng Y., Mackman N., Quehenberger P., Haase M., Luther T., Muller M., Bohrer H., Greten J., and et al Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem 1995; 270: 26419-26432.
112. Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-889.
113. Moll T., Czyz M., Holzmuller H., Hofer Warbinek R., Wagner E., Winkler H., Bach F.H., and Hofer E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem 1995; 270: 3849-3857.
114. Janknecht R. and Hunter T. A growing coactivator network. Nature 1996; 383: 22-23.
115. Gearing A.J. and Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
116. Lassalle P., Molet S., Janin A., Van der Heyden J., Tavernier J., Fiers W., Devos R., and Tonnel A.B. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996; 271: 20458-20464.